Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hepatitis B × Engerix-B × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 2 Papillomavirus Infections 2 Hepatitis B 1

Interventions

Tenofovir 3 entecavir 2 tenofovir alafenamide 1 human papillomavirus vaccine, L1 type 16, 18 1 Standard of Care 1 Practice Guidelines as Topic 1 Lamivudine 1 Engerix-B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637195 2020-01-03

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

GlaxoSmithKline

Phase 3 Completed

152 enrolled 21 charts

Uterine Cervical Neoplasms, Hepatitis B, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡